AMOKLAVIN-BID 625 mg

Indication

AMOKLAVIN-BID 625 mg (Amoxicillin 500 mg + Clavulanic acid 125 mg) is a broad-spectrum penicillin antibiotic combination used to treat adults and children with bacterial infections including community-acquired pneumonia, acute exacerbations of chronic bronchitis, sinusitis, otitis media, urinary tract infections, and skin/soft tissue infections caused by beta-lactamase-producing organisms.

Ingredients

• Amoxicillin
• Clavulanic Acid

Direction

Adults: One 625 mg tablet twice daily (BID) with meals. Duration depends on the infection type as directed by a physician. Swallow whole with water. Complete the full course even if symptoms improve.

Side effects

• Diarrhoea
• nausea
• vomiting — very common.
• Abdominal pain — common.
• Skin rash
• urticaria — common.
• Candidal overgrowth (oral or vaginal) — common.
• Elevated liver enzymes — uncommon.
• Anaphylaxis — rare but serious.

Precautions

• Do not use if allergic to penicillins
• cephalosporins
• or any beta
• lactam antibiotic.
• Obtain history of allergic reactions before prescribing.
• Can cause serious hypersensitivity reactions including anaphylaxis.
• Use with caution in renal impairment — dose interval adjustment required.
• May cause Clostridium difficile
• associated diarrhoea.
• Monitor liver function
• hepatotoxicity reported especially in older males and with prolonged use.
• May reduce the efficacy of oral contraceptives.
• Keep out of reach of children.